Abstract
It is estimated that there are 30,000 people who inject drugs in mainland Tanzania, with an approximate HIV prevalence of 35% in this key population. Drug use is criminalized in Tanzania and treatment options are limited. However, in February 2011, a cutting-edge medication-assisted treatment (MAT) clinic for opioid addiction offering methadone maintenance treatment was established at Muhimbili National Hospital in Dar es Salaam. The clinic, which began offering drug treatment and harm reduction services, now offers a multi-faceted array of health and social services to address the myriad of psychosocial and structural factors impacting the well-being of people who use drugs in that setting. These services include HIV counseling and testing and linkages to on-site HIV care and treatment services, screening and treatment for tuberculosis and other medical and mental disorders, and access to on-site social workers and affiliated occupational therapists. Social workers at the Muhimbili MAT clinic link MAT clients to community-based organizations that provide individual counseling, 12-step programs, family group therapy, and income-generating skills training, among other services for people who use drugs. This chapter uses a risk environment framework to describe the micro- and macro-environmental factors that place people who inject drugs at increased risk of HIV and documents innovative initiatives and partnerships that have been formed to address these factors through an in-depth case study of the Muhimbili National Hospital MAT clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
In response to a very low number of female clients enrolling into methadone treatment, another MAT clinic at Mwananyamala Regional Hospital, established in September 2012, piloted an approach, beginning in February 2013, allowing women dependent on heroin to enroll directly at the clinic rather than having to first attend the series of sessions at the CBOs. In addition, existing female clients were encouraged to recruit their peers and one day of the week was set aside for enrolling female clients only. This approach improved women’s enrollment into the methadone clinic at Mwananyamala, thereby increasing the proportion of female MAT clients.
- 2.
The first-line tuberculosis treatment regimen in Tanzania includes Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, and Streptomycin formulated in fixed drug combinations (United Republic of Tanzania 2013). The recommended standardized multi-drug resistant tuberculosis treatment regimen includes Amikacin, Ofloxacin/Levofloxacin, Pyrazinamide, Ethionamide, Cycloserine, and Ethambutol (if no resistance to Ethambutol is documented) (United Republic of Tanzania 2012).
References
Anderson, J. F., & Warren, L. D. (2004). Client retention in the British Columbia Methadone Program, 1996–1999. Canadian Journal of Public Health, 95(2), 104–109.
Beckerleg, S., Telfer, M., & Hundt, G. L. (2005). The rise of injecting drug use in East Africa: A case study from Kenya. Harm Reduction Journal, 2, 12. doi:10.1186/1477-7517-2-12.
Blankenship, K. M., Bray, S. J., Merson, M. H., Reinhard, E., Sherman, S. G., & El-Bassel, N. (2000). Structural interventions in public health. AIDS, 14(Suppl 1), S11–S21. doi:10.1097/00002030-200006001-00003.
Blankenship, K. M., Reinhard, E., Sherman, S. G., & El-Bassel, N. (2015). Structural interventions for HIV prevention among women who use drugs: A global perspective. JAIDS Journal of Acquired Immune Deficiency Syndromes, 69(Suppl 2), S140–S145. doi:10.1097/qai.0000000000000638.
Booth, R. E., Corsi, K. F., & Mikulich-Gilbertson, S. K. (2004). Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug & Alcohol Dependence, 74(2), 177–185. doi:10.1016/j.drugalcdep.2003.12.009.
Bruce, R. D. (2010). Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy, 21(2), 122–124. doi:10.1016/j.drugpo.2009.10.004.
Burke, S. E., Calabrese, S. K., Dovidio, J. F., Levina, O. S., Uuskula, A., Niccolai, L. M., Abel-Ollo, K., & Heimer, R. (2015). A tale of two cities: Stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. Social Science & Medicine, 130, 154–161. doi:10.1016/j.socscimed.2015.02.018.
Calabrese, S. K., Burke, S. E., Dovidio, J. F., Levina, O. S., Uuskula, A., Niccolai, L. M., & Heimer, R. (2016). Internalized HIV and drug stigmas: Interacting forces threatening health status and health service utilization among people with HIV who inject drugs in St. Petersburg, Russia. AIDS and Behavior, 20(1), 85–97. doi:10.1007/s10461-015-1100-4.
Ciccarone, D. (2009). Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market. International Journal of Drug Policy, 20(3), 277–282. doi:10.1016/j.drugpo.2008.08.003.
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., & Burls, A. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. Health Technology Assessment, 11(9), 1–171, iii–iv. doi:10.3310/hta11090.
Des Jarlais, D. C. (2000). Structural interventions to reduce HIV transmission among injecting drug users. AIDS, 14(Suppl 1), S41–S46. doi:10.1097/00002030-200006001-00006.
Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2), 146–157. doi:10.1176/appi.ps.201300235.
Gossop, M., Marsden, J., Stewart, D., & Treacy, S. (2001). Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence, 62(3), 255–264. doi:10.1016/s0376-8716(00)00211-8.
Gupta, A., Mbwambo, J., Mteza, I., Shenoi, S., Lambdin, B., Nyandindi, C., Doula, B. I., Mfaume, S., & Bruce, R. D. (2014). Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. International Journal of Tuberculosis and Lung Disease, 18(7), 793–798. doi:10.5588/ijtld.13.0208.
Lambdin, B. H., Bruce, R. D., Chang, O., Nyandindi, C., Sabuni, N., Zamudio-Haas, S., McCurdy, S., Masao, F., Ivo, Y., Msami, A., & Ubuguy, O. (2013). Identifying programmatic gaps: Inequities in harm reduction service utilization among male and female drug users in Dar es Salaam, Tanzania. PloS One, 8(6), e67062. doi:10.1371/journal.pone.0067062.
Lambdin, B. H., Masao, F., Chang, O., Kaduri, P., Mbwambo, J., Magimba, A., Sabuni, N., & Bruce, R. D. (2014). Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: A retrospective cohort study. Clinical Infectious Diseases, 59(5), 735–742. doi:10.1093/cid/ciu382.
Lambdin, B. H., Mbwambo, J. K., Josiah, R. M., & Bruce, R. D. (2015). Service integration: Opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania. Journal of the International AIDS Society, 18(1), 19936. doi:10.7448/ias.18.1.19936.
Liu, E., Liang, T., Shen, L., Zhong, H., Wang, B., Wu, Z., & Detels, R. (2009). Correlates of methadone client retention: A prospective cohort study in Guizhou province, China. International Journal of Drug Policy, 20(4), 304–308. doi:10.1016/j.drugpo.2008.09.004.
Magimba, A. (2015). National scale up lan for medically assisted treatment using methadone for people who use drugs in Tanzania. Dar es Salaam: Ministry of Health and Social Welfare.
Magura, S., Casriel, C., Goldsmith, D. S., Strug, D. L., & Lipton, D. S. (1988). Contingency contracting with polydrug-abusing methadone patients. Addictive Behaviors, 13(1), 113–118. doi:10.1016/0306-4603(88)90035-4.
McCurdy, S., & Kaduri, P. (2016). The political economy of heroin and crack in Tanzania. Review of African Political Economy, 43(148), 312–319. doi:10.1080/03056244.2016.1170678.
McCurdy, S., & Maruyama, H. (2013). Heroin use, trafficking, and intervention approache in Sub-saharan Africa: Local and global contexts. In T. Giles-Vernick & J. L. A. Webb Jr. (Eds.), Global health in Africa: Historical perspectives on disease control (pp. 211–232). Athens: Ohio University Press.
McCurdy, S. A., Williams, M. L., Kilonzo, G. P., Ross, M. W., & Leshabari, M. T. (2005a). Heroin and HIV risk in Dar es Salaam, Tanzania: Youth hangouts, mageto and injecting practices. AIDS Care, 17(Suppl 1), S65–S76. doi:10.1080/09540120500120930.
McCurdy, S. A., Williams, M. L., Ross, M. W., Kilonzo, G. P., & Leshabari, M. T. (2005b). A theme issue by, for, and about Africa: New injecting practice increases HIV risk among drug users in Tanzania. BMJ, 331(7519), 778. doi:10.1136/bmj.331.7519.778-a.
McCurdy, S. A., Ross, M. W., Kilonzo, G. P., Leshabari, M. T., & Williams, M. L. (2006). HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania. Drug and Alcohol Dependence, 82(Suppl 1), S23–S27. doi:10.1016/s0376-8716(06)80004-9.
McCurdy, S., Kilonzo, G. P., Williams, M., & Kaaya, S. (2007). Harm reduction in Tanzania: An urgent need for multisectoral intervention. International Journal of Drug Policy, 18(3), 155–159. doi:10.1016/j.drugpo.2007.05.001.
McCurdy, S. A., Ross, M. W., Williams, M. L., Kilonzo, G. P., & Leshabari, M. T. (2010). Flashblood: Blood sharing among female injecting drug users in Tanzania. Addiction, 105(6), 1062–1070. doi:10.1111/j.1360-0443.2010.02908.x.
McNeil, D Jr. (2010). Desperate addicts inject others’ blood. New York Times. New York City.
Metzger, D. S., Woody, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., & Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes, 6(9), 1049–1056.
Mlunde, L. B., Sunguya, B. F., Mbwambo, J. K., Ubuguyu, O. S., Shibanuma, A., Yasuoka, J., & Jimba, M. (2016). A mismatch between high-risk behaviors and screening of infectious diseases among people who inject drugs in Dar es Salaam, Tanzania. PloS One, 11(2), e0148598. doi:10.1371/journal.pone.0148598.
MoHSW & DCC. (2014). Guideline for medically-assisted treatment of opioid dependence in Tanzania. Unpublished Draft.
MoHSW & DCC (2015). Guideline for medically assisted treatment of opioid dependence in Tanzania (2nd ed.). Dar es Salaam.
NACP (2014). Consensus estimates on key population size and HIV prevalence in Tanzania. Dar es Salaam: National AIDS Control Program.
Njenga, F., Kiima, D., Siminyu, M., Munyi, E., Abdool, R., Muthui, M., Lambdin, B., Mbwambo, J., Mwamburi, E., McCurdy, S., Pick, B., Anderson, G., Mital, S., & Needle, R. (2012). Heroin scarcity in coastal Kenya: Consequence for persons who inject drugs (PWID) and national and provincial response to the crisis. XIX International AIDS Conference. Washington, DC.
Nyandindi, C., Mbwambo, J., McCurdy, S., Lambdin, B., Copenhaver, M., & Bruce, R. (2014). Prevalence of HIV, hepatitis C and depression among people who inject drugs in the Kinondoni Municipality in Dar Es Salaam, Tanzania. Drug & Alcohol Dependence, 140, e164. doi:10.1016/j.drugalcdep.2014.02.461.
Office of National Drug Control Policy. (n.d.). The international heroin market. https://www.whitehouse.gov/ondcp/global-heroin-market. Accessed 14 Oct 2016.
Ratliff, E. A., Kaduri, P., Masao, F., Mbwambo, J. K., & McCurdy, S. A. (2016). Harm reduction as a complex adaptive system: A dynamic framework for analyzing Tanzanian policies concerning heroin use. International Journal of Drug Policy, 30, 7–16. doi:10.1016/j.drugpo.2015.12.008.
Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3), 193–201. doi:10.1016/j.drugpo.2008.10.003.
Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medicine, 61, 1026–1044. doi:10.1016/j.socscimed.2004.12.024.
Saleem, H. T., Mushi, D., Hassan, S., Douglas Bruce, R., Cooke, A., Mbwambo, J., & Lambdin, B. H. (2016). ‘Can’t you initiate me here?’: Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania. International Journal of Drug Policy, 30, 59–65. doi:10.1016/j.drugpo.2015.12.009.
Sarasvita, R., Tonkin, A., Utomo, B., & Ali, R. (2012). Predictive factors for treatment retention in methadone programs in Indonesia. Journal of Substance Abuse Treatment, 42(3), 239–246. doi:10.1016/j.jsat.2011.07.009.
Soyka, M., Zingg, C., Koller, G., & Kuefner, H. (2008). Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study. International Journal of Neuropsychopharmacology, 11(5), 641–653. doi:10.1017/s146114570700836x.
The Economist. (2015). The smack track: Drug smuggling in Africa. 17 January 2015. http://www.economist.com/news/middle-east-and-africa/21639560-east-african-states-are-being-undermined-heroin-smuggling-smack-track. Accessed 29 Apr 2017.
Tran, O. C., Bruce, R. D., Masao, F., Ubuguyu, O., Sabuni, N., Mbwambo, J., & Lambdin, B. H. (2015). Implementation and operational research: Linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes, 69(2), e43–e48. doi:10.1097/qai.0000000000000582.
Ubuguyu, O., Tran, O. C., Bruce, R. D., Masao, F., Nyandindi, C., Sabuni, N., McCurdy, S., Mbwambo, J., & Lambdin, B. H. (2016). Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania. International Journal of Drug Policy, 30, 74–81. doi:10.1016/j.drugpo.2016.03.005.
United Republic of Tanzania. (1995). The Drugs and Prevention of Illicit Traffic in Drugs Act, Act No. 9 of 1995. United Republic of Tanzania. https://www.fiu.go.tz/PreventionOfIllicitTrafficInDrugsAct.pdf. Accessed 29 Apr 2017.
United Republic of Tanzania. (2012). Operational guidelines for the management of drug resistant TB in Tanzania (1st ed.). Dar es Salaam: National TB and Leprosy Programme, Ministry of Health and Social Welfare. https://drive.google.com/file/d/0By0MeTLkdAyFbmhORUtqa09hWUE/view. Accessed 29 Apr 2017.
United Republic of Tanzania. (2013). Manual for the management of tuberculosis and leprosy (6th ed.). Dar es Salaam: National TB and Leprosy Programme Ministry of Health and Social Welfare.
United Republic of Tanzania. (2014). Global AIDS response country progress report. Dar es Salaam: Ministry of Health and Social Welfare. http://www.unaids.org/sites/default/files/country/documents/TZA_narrative_report_2014.pdf. Accessed 29 Apr 2017.
United Republic of Tanzania. (2015). The Drug Control and Enforcement Act, Act No. 5 of 2015. United Republic of Tanzania. http://www.parliament.go.tz/uploads/documents/1476204842-GN%20173-DRUGS%20CONTROL%20AND%20ENFORCEMENT%20(GENERAL)%20REGULATIONS,%202016.pdf. Accessed 29 Apr 2017.
WHO. (2012). Global tuberculosis report 2012. Geneva: WHO.
WHO. (2013). Systematic screening for active tuberculosis: Principles and recommendations. Geneva: WHO.
WHO, UNODC, & UNAIDS. (2012). WHO, UNODC, UNAIDS technical guide for countries to set targets for universal acces to HIV prevention, treatment and care for injecting drug users – 2012 revision. Geneva: WHO.
Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. Lancet, 376(9738), 355–366. doi:10.1016/s0140-6736(10)60832-x.
Zamudio-Haas, S. (2013). Providing medication assisted treatment (MAT) as an HIV prevention intervention: Programmatic strategies to maximize service utilization in Dar es Salaam, Tanzania. Doctoral dissertation, University of California-Berkeley.
Zamudio-Haas, S., Mahenge, B., Saleem, H., Mbwambo, J., & Lambdin, B. H. (2016). Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania. International Journal of Drug Policy, 30, 43–51. doi:10.1016/j.drugpo.2016.01.012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Mbwambo, J., Saleem, H.T., Kaduri, P., Lambdin, B.H., McCurdy, S.A. (2018). Addressing the Micro- and Macro-Environmental Vulnerabilities to HIV of People Who Inject Drugs in Tanzania: A Case Study of the Muhimbili Medication-Assisted Treatment Clinic. In: Kerrigan, D., Barrington, C. (eds) Structural Dynamics of HIV. Social Aspects of HIV, vol 4. Springer, Cham. https://doi.org/10.1007/978-3-319-63522-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-63522-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63521-7
Online ISBN: 978-3-319-63522-4
eBook Packages: MedicineMedicine (R0)